Phase 3 randomized <scp>COMMODORE</scp> 2 trial: Crovalimab versus eculizumab in patients with <scp>paroxysmal nocturnal hemoglobinuria</scp> naive to complement inhibitionAlexander Röth, Bing Han, Hongyan Tong et al.|American Journal of Hematology|2024Cited by 46